CliffBio
small molecule

POTASSIUM CHLORIDE

POTASSIUM CHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyTris. →See this company's full patent-cliff portfolio

Drug detail

Brand namePOTASSIUM CHLORIDE
Active ingredientPOTASSIUM CHLORIDE
Strength8MEQ
Dosage formCAPSULE, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalMarch 2016
Marketing statusDISCN

More from Tris.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

POTASSIUM CHLORIDE patent cliff — loss of exclusivity — | CliffBio